iCure, Top Search Ranking... Stock Price -6.03%
IQVIA has newly appeared among the top searched stocks.
As of 12:32 PM on the 18th, IQVIA is trading at 63,900 KRW, down 6.03% from the previous day. This represents an 18.49% decline compared to February 15. IQVIA is known as a company possessing core technology in transdermal drug delivery systems.
Today, foreigners are tentatively recorded as net buyers of 4,000 shares. Over the past five days, individual investors have been net sellers of 30,205 shares, while foreigners and institutions have been net buyers of 21,494 shares and 21,149 shares, respectively.
On February 16, IQVIA was a market issue with the headline, "Despite Celltrion's success in Phase 3 clinical trials for dementia patches, stock declines."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.